CapsoVision
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
18805 Cox Ave Ste 250, Saratoga, Califor...Phone Number
(408) 624-1488Website
www.capsovision.comRevenue
$13.6 MillionStock Symbol
CVIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About CapsoVision
CapsoVision, Inc. (capsovision.com) is a global medical device innovator located in Silicon Valley, California. A privately held company with out-of-the-box thinking and top-notch talent, CapsoVision's mission is to empower physicians and patients with innovative technologies that improve diagnostic confidence and clinical outcomes. CapsoVision currently offers the CapsoCam Plus capsule endoscopy system in over 70 countries.Explore more
CapsoVision Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CapsoVision your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CapsoVision, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CapsoVision launches new products
Check out if CapsoVision is spiking on competitors!
Check if CapsoVision has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CapsoVision has new funding data
Earning: See what the market has to say on CapsoVision recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at CapsoVision
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if CapsoVision had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to CapsoVision
Compare insights from companies similar to CapsoVision, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CapsoVision is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CapsoVision is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CapsoVision.
CapsoVision financials insights
Gather financial insights about CapsoVision, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$2.5M
Private Equity
$1.5M
2012
Private Equity
$589K
Private Equity
$3.7M
2014
Private Equity
$15.9M
2016
Private Equity
$4.6M
2020
Debt
$350K
2025
IPO
$27.5M
2026
Stock/Share Issuance
$14M
CapsoVision Tech Stack
A closer look at the technologies used by CapsoVision
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Initial Public Offering (IPO)
IPO, Funding
Project
Research & Development, Compliance, Medical Research, Healthcare Technology, Regulations
Facilities Relocation / Expansion
Facilities Relocation/Expansion
CapsoVision News & Media
CapsoVision Q1 Earnings Call Highlights
CapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal imaging platform. On the company’s first-quarter 2026 earnings call, President and Chief ExecutiveCapsoVision Reports First Quarter 2026 Financial Results
SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for its first quarter ended March 31, 2026.CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026
SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release first quarter 2026 financial results on Thursday, May 14, 2026, after the close of market. CapsoVision will host a corresponding conference call and a live webcast at 1:30 pm PT / 4:30 pm ET on the same day to discuss the results andCapsoVision Q4 Earnings Call Highlights
CapsoVision (NASDAQ:CV) executives highlighted continued commercial growth for its CapsoCam Plus small-bowel capsule endoscopy product and provided updates on regulatory and clinical milestones for the company’s pipeline during its fourth-quarter and full-year 2025 earnings call. Commercial momentu
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CapsoVision
Sign Up For FreeTo access detailed company insights
CapsoVision, Inc. (capsovision.com) is a global medical device innovator located in Silicon Valley, California. A privately held company with out-of-the-box thinking and top-notch talent, CapsoVision's mission is to empower physicians and patients with innovative technologies that improve diagnostic confidence and clinical outcomes. CapsoVision cur... Read More
